{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T16:59:17Z","timestamp":1772729957707,"version":"3.50.1"},"reference-count":108,"publisher":"Informa UK Limited","issue":"3","funder":[{"name":"Novartis Healthcare Pvt. Ltd"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2026,3,4]]},"DOI":"10.1080\/17474086.2025.2610281","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T05:43:01Z","timestamp":1766986981000},"page":"305-319","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Addressing unmet needs in chronic myeloid leukemia in chronic phase treated with two or more tyrosine kinase inhibitors: insights from literature and Indian clinical practice"],"prefix":"10.1080","volume":"19","author":[{"given":"Arijit","family":"Nag","sequence":"first","affiliation":[{"name":"TATA Medical Center","place":["Kolkata, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishnu","family":"Sharma","sequence":"additional","affiliation":[{"name":"SMS Medical College","place":["Jaipur, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadashivudu","family":"Gundeti","sequence":"additional","affiliation":[{"name":"Nizam\u2019s Institute of Medical Sciences","place":["Hyderabad, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhausaheb","family":"Bagal","sequence":"additional","affiliation":[{"name":"Tata Memorial Center","place":["Mumbai, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuvra Neel","family":"Baul","sequence":"additional","affiliation":[{"name":"N.R.S Medical College & Hospital","place":["Kolkata, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jina","family":"Bhattacharya","sequence":"additional","affiliation":[{"name":"Guwahati Medical College & Hospital","place":["Guwahati, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishi","family":"Jain","sequence":"additional","affiliation":[{"name":"Novartis Healthcare Pharmaceuticals Ltd","place":["Mumbai, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabindra Kumar","family":"Jena","sequence":"additional","affiliation":[{"name":"SCB Medical College and Hospital","place":["Cuttack, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujeet","family":"Kumar","sequence":"additional","affiliation":[{"name":"Medanta Hospital Lucknow","place":["Lucknow, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemant","family":"Malhotra","sequence":"additional","affiliation":[{"name":"Sri Ram Cancer & Super-Specialty Center, Mahatma Gandhi Medical College Hospital, Mahatma Gandhi University of Medical Sciences & Technology","place":["Jaipur, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuldeep","family":"Saini","sequence":"additional","affiliation":[{"name":"Novartis Healthcare Pharmaceuticals Ltd","place":["Mumbai, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lalit Mohan","family":"Sharma","sequence":"additional","affiliation":[{"name":"Mahatma Gandhi University of Medical Sciences and Technology","place":["Jaipur, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Disha","family":"Shetty","sequence":"additional","affiliation":[{"name":"Novartis Healthcare Pharmaceuticals Ltd","place":["Mumbai, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailendra Prasad","family":"Verma","sequence":"additional","affiliation":[{"name":"King George\u2019s Medical University","place":["Lucknow, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Yadav","sequence":"additional","affiliation":[{"name":"Sanjay Gandhi Postgraduate Institute of Medical Sciences","place":["Lucknow, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Velu","family":"Nair","sequence":"additional","affiliation":[{"name":"Apollo Hospitals International Limited","place":["Gandhinagar, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/GO.21.00194"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.580759"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26642"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JGO.2015.002667"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-020-00185-z"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00823-9"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.ijmr_1090_21"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.630.630"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.adengl.2014.07.010"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2014.07.005"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2022.05.002"},{"issue":"4","key":"e_1_3_7_14_1","first-page":"169","article-title":"A comprehensive review of chronic myeloid leukemia: an Indian perspective","volume":"45","author":"Varma PK","year":"2019","unstructured":"Varma PK, Patel DM, Trivedi PJ, et al. A comprehensive review of chronic myeloid leukemia: an Indian perspective. J Assoc Genetic Technologists. 2019;45(4):169\u2013174.","journal-title":"J Assoc Genetic Technologists"},{"key":"e_1_3_7_15_1","unstructured":"Ministry of Health & Family Welfare. Government of India. List of new drugs approved in the year 2023 till date. [cited]. https:\/\/cdsco.gov.in\/opencms\/opencms\/system\/modules\/CDSCO.WEB\/elements\/download_file_division.jsp?num_id=MTA4MDA="},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25306"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-137079"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01055-9"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-06-291922"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-140402"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2017.1262758"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2017.1330144"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0842-9"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14143300"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-025-02664-w"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0776-2"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-02048-y"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2024.0007"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx219"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16971"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.03.006"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.4076"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02187-w"},{"issue":"7","key":"e_1_3_7_34_1","first-page":"421","article-title":"Javier the \u201chit hard and hit early\u201d approach to the treatment of chronic myeloid leukemia: implications of the updated national comprehensive Cancer network clinical practice guidelines for routine practice","volume":"11","author":"Akard LPA","year":"2013","unstructured":"Akard LPA, Maher H, Charles E. Javier the \u201chit hard and hit early\u201d approach to the treatment of chronic myeloid leukemia: implications of the updated national comprehensive Cancer network clinical practice guidelines for routine practice. Clin Adv Hematol Oncol. 2013;11(7):421\u2013432.","journal-title":"Clin Adv Hematol Oncol"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-221531"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.110"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2011.06.009"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.064337"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2015(08)04"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.4051.4051"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-169772"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2018.11.005"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0915-9"},{"key":"e_1_3_7_44_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1138683"},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2015.03.006"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.1587.1587"},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11657"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40959-015-0008-5"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2022.100968"},{"key":"e_1_3_7_50_1","unstructured":"Gleevec (imatinib mesylate) package insert. Initial us FDA approval: 2001. [cited 2022 Aug]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/021588s062lbl.pdf"},{"key":"e_1_3_7_51_1","unstructured":"Sprycel (dasatinib) package insert. Initial us FDA approval: 2006. [cited 2024 Jul]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/021986s028lbl.pdf"},{"key":"e_1_3_7_52_1","unstructured":"Tasigna (nilotinib) package insert. Initial us FDA approval: 2007. [cited 2024 Feb]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/022068s041lbl.pdf"},{"key":"e_1_3_7_53_1","unstructured":"Bosulif (bosutinib) package insert. Initial us FDA approval: 2012. [cited 2024 Dec]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/203341s026lbl.pdf"},{"key":"e_1_3_7_54_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2018.1480719"},{"key":"e_1_3_7_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3071"},{"key":"e_1_3_7_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2016.02.028"},{"key":"e_1_3_7_57_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000843528.26169.66"},{"key":"e_1_3_7_58_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.8154"},{"key":"e_1_3_7_59_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15164161"},{"key":"e_1_3_7_60_1","unstructured":"Unmet Needs in CML. 2022 [cited 2023 Nov 29]. Available from: https:\/\/www.hcp.novartis.com\/products\/scemblix\/ph-cml\/unmet-needs-in-cml\/"},{"key":"e_1_3_7_61_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1855340"},{"key":"e_1_3_7_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(21)00333-1"},{"key":"e_1_3_7_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-024-03830-z"},{"issue":"5","key":"e_1_3_7_64_1","first-page":"521","article-title":"Management of adverse events associated with tyrosine kinase inhibitor use in adult patients with chronic myeloid leukemia in chronic phase: an advanced practice perspective","volume":"12","author":"Bauer S","year":"2021","unstructured":"Bauer S, Comer H, Ramsey B, et al. Management of adverse events associated with tyrosine kinase inhibitor use in adult patients with chronic myeloid leukemia in chronic phase: an advanced practice perspective. J Adv Pract Oncol. 2021;12(5):521\u2013533.","journal-title":"J Adv Pract Oncol"},{"key":"e_1_3_7_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1808"},{"key":"e_1_3_7_66_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1369246"},{"key":"e_1_3_7_67_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000969576.83189.62"},{"key":"e_1_3_7_68_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.170"},{"key":"e_1_3_7_69_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.093724"},{"key":"e_1_3_7_70_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijmpo.ijmpo_160_16"},{"key":"e_1_3_7_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2016.02.040"},{"issue":"3","key":"e_1_3_7_72_1","first-page":"142","article-title":"Non-adherence to cml therapy and its clinical implications in India","volume":"30","author":"Menon H","year":"2017","unstructured":"Menon H. Non-adherence to cml therapy and its clinical implications in India. Natl Med J India. 2017;30(3):142\u2013147.","journal-title":"Natl Med J India"},{"key":"e_1_3_7_73_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-09-2896"},{"key":"e_1_3_7_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(02)00096-X"},{"key":"e_1_3_7_75_1","first-page":"100403","article-title":"BCR-ABL kinase domain mutations in cml patients, experience from a tertiary care center in North India","volume":"21","author":"Akhilesh S","year":"2024","unstructured":"Akhilesh S, Shah A, Ashish A, et al. BCR-ABL kinase domain mutations in cml patients, experience from a tertiary care center in North India. Leuk Res Rep. 2024;21:100403.","journal-title":"Leuk Res Rep"},{"key":"e_1_3_7_76_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-024-01769-z"},{"key":"e_1_3_7_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02411-7"},{"key":"e_1_3_7_78_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022538"},{"key":"e_1_3_7_79_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-01829-9"},{"key":"e_1_3_7_80_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02159-0"},{"key":"e_1_3_7_81_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000268"},{"key":"e_1_3_7_82_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1163137"},{"key":"e_1_3_7_83_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009984"},{"key":"e_1_3_7_84_1","volume-title":"StatPearls [internet]","author":"Eden RE","year":"2023","unstructured":"Eden RE, Coviello JM. Chronic myelogenous leukemia. In: StatPearls [internet]. Treasure Island (FL): StatPearls Publishing; 2023."},{"key":"e_1_3_7_85_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2022000329"},{"key":"e_1_3_7_86_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1783444"},{"key":"e_1_3_7_87_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003570"},{"key":"e_1_3_7_88_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.282184"},{"key":"e_1_3_7_89_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells12131703"},{"key":"e_1_3_7_90_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-302679"},{"key":"e_1_3_7_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2021.02.003"},{"key":"e_1_3_7_92_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2010.06.008"},{"key":"e_1_3_7_93_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014689"},{"key":"e_1_3_7_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2014.10.005"},{"key":"e_1_3_7_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(22)00882-5"},{"key":"e_1_3_7_96_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902328"},{"key":"e_1_3_7_97_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2025016042"},{"key":"e_1_3_7_98_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-187322"},{"key":"e_1_3_7_99_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-04562-5"},{"key":"e_1_3_7_100_1","unstructured":"The max foundation: cancer programs.[cited. Available from: https:\/\/themaxfoundation.org\/cancer-programs\/"},{"key":"e_1_3_7_101_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26686"},{"key":"e_1_3_7_102_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306494"},{"key":"e_1_3_7_103_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012082"},{"key":"e_1_3_7_104_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V120.21.3749.3749"},{"key":"e_1_3_7_105_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-739086"},{"key":"e_1_3_7_106_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01469-6"},{"key":"e_1_3_7_107_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001944"},{"key":"e_1_3_7_108_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2018.1508023"},{"key":"e_1_3_7_109_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2017.23.2.214"},{"key":"e_1_3_7_110_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0259076"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2025.2610281","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T15:59:21Z","timestamp":1772726361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2025.2610281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":108,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,4]]}},"alternative-id":["10.1080\/17474086.2025.2610281"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2025.2610281","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-09-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}